PharmaCorp Announces CFO Transition and Appointment of Andrew Hodson as Chief Financial Officer

New CFO Andrew Hodson brings to PharmaCorp more than 11 years of financial leadership, including capital markets experience and over six years leading global finance teams in high-growth and acquisition-driven businesses SASKATOON, Saskatchewan, Oct. 14, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, […]